Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 100 shares, a drop of 88.9% from the February 28th total of 900 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is currently 0.0 days.

Fidelity Disruptive Medicine ETF Stock Down 1.6 %

Shares of FMED stock traded down $0.39 on Friday, reaching $23.83. 1,752 shares of the stock were exchanged, compared to its average volume of 5,415. The stock has a market cap of $50.05 million, a P/E ratio of 42.35 and a beta of 0.94. The firm has a 50 day moving average of $25.34 and a two-hundred day moving average of $25.61. Fidelity Disruptive Medicine ETF has a 1-year low of $23.32 and a 1-year high of $26.79.

Institutional Trading of Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC boosted its stake in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 8.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 583,615 shares of the company’s stock after acquiring an additional 43,788 shares during the quarter. Wealth Enhancement Advisory Services LLC owned about 27.79% of Fidelity Disruptive Medicine ETF worth $14,392,000 at the end of the most recent reporting period.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.